DEVELOPMENT AND OPTIMIZATION OF SILYMARIN-LOADED MULTI WALLED CARBON NANOTUBES (SIL-MWCNTS) FOR HEPATIC CANCER TREATMENT
INDIAN DRUGS · 28.02.2026 · 63 (02) · 40-48
DOI: 10.53879/id.63.02.16178 ↗Kurz gefasst
Fachartikel in der Zeitschrift INDIAN DRUGS, online erschienen am 02.03.2026. Verfasst von Saurabh Morparia und 1 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
This study developed silymarin-loaded multi-walled carbon nanotubes (SIL-MWCNTs) to improve hepatic cancer treatment. Silymarin, a flavonoid with hepatoprotective properties, faces challenges in conventional therapy due to poor solubility and bioavailability. The research aimed to enhance its bioavailability and targeted delivery by encapsulation within MWCNTs. Using a 32 -factorial design, optimal formulations achieved a particle size of 717.205 nm, zeta potential of -25.08 mV, and 71.74% encapsulation efficiency. Confirmation via DSC, FTIR, and TEM analyses validated silymarin’s incorporation. In vitro studies showed sustained drug release and moderate cytotoxicity against HepG2 cells (IC50: 138.23 µg mL-1). This encapsulation strategy promises enhanced therapeutic efficacy and reduced adverse effects through targeted delivery.
Zitieren
APA
Morparia, S., & Suvarna, V. (2026). DEVELOPMENT AND OPTIMIZATION OF SILYMARIN-LOADED MULTI WALLED CARBON NANOTUBES (SIL-MWCNTS) FOR HEPATIC CANCER TREATMENT. INDIAN DRUGS, 63(02), 40-48. https://doi.org/10.53879/id.63.02.16178
Vancouver
Morparia S, Suvarna V. DEVELOPMENT AND OPTIMIZATION OF SILYMARIN-LOADED MULTI WALLED CARBON NANOTUBES (SIL-MWCNTS) FOR HEPATIC CANCER TREATMENT. INDIAN DRUGS. 2026;63(02):40-48. doi:10.53879/id.63.02.16178
BibTeX
@article{Morparia2026,
author = {Morparia, Saurabh and Suvarna, Vasanti},
title = {DEVELOPMENT AND OPTIMIZATION OF SILYMARIN-LOADED MULTI WALLED CARBON NANOTUBES (SIL-MWCNTS) FOR HEPATIC CANCER TREATMENT},
journal = {INDIAN DRUGS},
year = {2026},
volume = {63},
number = {02},
pages = {40--48},
doi = {10.53879/id.63.02.16178}
}
EUVIMED